Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong · Delayed Price · Currency is HKD 3.340
+0.240 (7.74%)
Mar 10, 2026, 4:08 PM HKT
Hua Medicine (Shanghai) Market Cap
Hua Medicine (Shanghai) has a market cap or net worth of 3.06 billion as of March 10, 2026. Its market cap has increased by 86.93% in one year.
Market Cap
3.06B
Enterprise Value
2.24B
Revenue
406.16M
Ranking
n/a
PE Ratio
2.59
Stock Price
3.34
Market Cap Chart
Since September 14, 2018, Hua Medicine (Shanghai)'s market cap has decreased from 8.71B to 3.06B, a decrease of -64.83%. That is a compound annual growth rate of -13.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 3.06B | 0.65% |
| Dec 31, 2025 | 3.04B | 112.44% |
| Dec 31, 2024 | 1.43B | -25.71% |
| Dec 29, 2023 | 1.93B | -46.67% |
| Dec 30, 2022 | 3.62B | -0.33% |
| Dec 31, 2021 | 3.63B | -34.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SSY Group | 7.28B |
| Beijing Tong Ren Tang Chinese Medicine Company | 7.18B |
| China Shineway Pharmaceutical Group | 6.90B |
| Edding Genor Group Holdings | 5.34B |
| VISEN Pharmaceuticals | 3.37B |
| Jacobson Pharma Corporation | 2.56B |
| Essex Bio-Technology | 2.29B |
| Golden Throat Holdings Group Company | 2.27B |